Skip to main content
Top

27-09-2024 | Ewing's sarcoma | RESEARCH ARTICLE

Incidence trends, overall survival, and metastasis prediction using multiple machine learning and deep learning techniques in pediatric and adolescent population with osteosarcoma and Ewing’s sarcoma: nomogram and webpage

Authors: Chengyuan Zhou, Han Li, Hao Zeng, Pan Wang

Published in: Clinical and Translational Oncology

Login to get access

Abstract

Objective

The objective of this study was to analyze the incidence and overall survival (OS) of osteosarcoma (OSC) and Ewing’s sarcoma (EWS) in a pediatric and adolescent population, employing machine learning (ML) and deep learning (DL) models to predict the likelihood of metastasis.

Methods

Involving 2465 OSC and 1373 EWS patients aged 0–19 years, from 2004 to 2020. ML techniques—Lasso, Ridge Regression, Elastic Net, and Random Forest—were used alongside a deep learning model based on TensorFlow and Keras, to construct predictive models for metastasis. These models were optimized using grid search with cross-validation and evaluated on their performance metrics, including AUC, sensitivity, and accuracy. The variables’ importance in metastasis prediction was determined using SHAP values. Statistical analysis was performed using R software, and an online nomogram was developed for clinical use.

Results

The age-adjusted incidence of OSC and EWS from 2004 to 2020 showed a significant uptrend. The deep learning model, iterated 50 times, outperformed the Random Forest model in both loss and accuracy stabilization. The nomogram created demonstrated accurate survival predictions, as evidenced by its calibration curves and the distinction between high and low-risk groups.

Conclusion

The increasing trend in age-adjusted incidence of OSC and EWS highlights the need for continued research and improved therapeutic strategies in this domain. The study employed ML and DL models to predict distant metastasis in pediatric and adolescent patients with OSC and EWS, providing a valuable tool for prognosis. The online nomogram developed as a part of this research enhances the models' clinical utility, offering an accessible means for clinicians to predict survival outcomes effectively.
Appendix
Available only for authorised users
Literature
1.
go back to reference Isakoff MS, Bielack SS, Meltzer P, Gorlick R. Osteosarcoma: current treatment and a collaborative pathway to success. JCO. 2015;33:3029–35.CrossRef Isakoff MS, Bielack SS, Meltzer P, Gorlick R. Osteosarcoma: current treatment and a collaborative pathway to success. JCO. 2015;33:3029–35.CrossRef
2.
go back to reference Shannon Orr W, Denbo JW, Billups CA, Wu J, Navid F, Rao BN, et al. Analysis of prognostic factors in extraosseous ewing sarcoma family of tumors: review of St. Jude Children’s research hospital experience. Ann Surg Oncol. 2012;19:3816–22.CrossRefPubMed Shannon Orr W, Denbo JW, Billups CA, Wu J, Navid F, Rao BN, et al. Analysis of prognostic factors in extraosseous ewing sarcoma family of tumors: review of St. Jude Children’s research hospital experience. Ann Surg Oncol. 2012;19:3816–22.CrossRefPubMed
3.
go back to reference Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA: Cancer J Clin. 2014;64:83–103.PubMed Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA: Cancer J Clin. 2014;64:83–103.PubMed
4.
go back to reference Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, et al. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. JCO. 2005;23:2004–11.CrossRef Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, et al. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. JCO. 2005;23:2004–11.CrossRef
5.
go back to reference Meyers PA, Heller G, Healey JH, Huvos A, Applewhite A, Sun M, et al. Osteogenic sarcoma with clinically detectable metastasis at initial presentation. JCO. 1993;11:449–53.CrossRef Meyers PA, Heller G, Healey JH, Huvos A, Applewhite A, Sun M, et al. Osteogenic sarcoma with clinically detectable metastasis at initial presentation. JCO. 1993;11:449–53.CrossRef
6.
go back to reference Kager L, Zoubek A, Pötschger U, Kastner U, Flege S, Kempf-Bielack B, et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant cooperative osteosarcoma study group protocols. JCO. 2003;21:2011–8.CrossRef Kager L, Zoubek A, Pötschger U, Kastner U, Flege S, Kempf-Bielack B, et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant cooperative osteosarcoma study group protocols. JCO. 2003;21:2011–8.CrossRef
8.
go back to reference Kim S, Lee S, Choi J-I, Cho H. Binary genetic algorithm for optimal joinpoint detection: application to cancer trend analysis. Stat Med. 2021;40:799–822.CrossRefPubMed Kim S, Lee S, Choi J-I, Cho H. Binary genetic algorithm for optimal joinpoint detection: application to cancer trend analysis. Stat Med. 2021;40:799–822.CrossRefPubMed
9.
go back to reference Al-Lawati NA, Shenoy SM, Al-Bahrani BJ, Al-Lawati JA. Increasing thyroid cancer incidence in oman: a joinpoint trend analysis. Oman Med J. 2020;35:e98–e98.CrossRefPubMedPubMedCentral Al-Lawati NA, Shenoy SM, Al-Bahrani BJ, Al-Lawati JA. Increasing thyroid cancer incidence in oman: a joinpoint trend analysis. Oman Med J. 2020;35:e98–e98.CrossRefPubMedPubMedCentral
10.
go back to reference Ilic M, Ilic I. Cancer mortality in Serbia, 1991–2015: an age-period-cohort and joinpoint regression analysis. Cancer Commun. 2018;38:10.CrossRef Ilic M, Ilic I. Cancer mortality in Serbia, 1991–2015: an age-period-cohort and joinpoint regression analysis. Cancer Commun. 2018;38:10.CrossRef
11.
go back to reference Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. JCO. 2008;26:1364–70.CrossRef Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. JCO. 2008;26:1364–70.CrossRef
12.
go back to reference Pan X, Yang W, Chen Y, Tong L, Li C, Li H. Nomogram for predicting the overall survival of patients with inflammatory breast cancer: a SEER-based study. The Breast. 2019;47:56–61.CrossRefPubMed Pan X, Yang W, Chen Y, Tong L, Li C, Li H. Nomogram for predicting the overall survival of patients with inflammatory breast cancer: a SEER-based study. The Breast. 2019;47:56–61.CrossRefPubMed
13.
go back to reference van den Hoven I, van Klaveren D, Verheuvel NC, Van La Parra RFD, Voogd AC, De Roos WK, et al. Predicting the extent of nodal involvement for node positive breast cancer patients: development and validation of a novel tool. J Surg Oncol. 2019;120:578–86.CrossRefPubMedPubMedCentral van den Hoven I, van Klaveren D, Verheuvel NC, Van La Parra RFD, Voogd AC, De Roos WK, et al. Predicting the extent of nodal involvement for node positive breast cancer patients: development and validation of a novel tool. J Surg Oncol. 2019;120:578–86.CrossRefPubMedPubMedCentral
14.
go back to reference Zhang Y, Zheng D, Xie J, Li Y, Wang Y, Li C, et al. Development and validation of web-based nomograms to precisely predict conditional risk of site-specific recurrence for patients with completely resected non-small cell lung cancer: a multiinstitutional study. Chest. 2018;154:501–11.CrossRefPubMed Zhang Y, Zheng D, Xie J, Li Y, Wang Y, Li C, et al. Development and validation of web-based nomograms to precisely predict conditional risk of site-specific recurrence for patients with completely resected non-small cell lung cancer: a multiinstitutional study. Chest. 2018;154:501–11.CrossRefPubMed
15.
go back to reference Hu T, Wang S, Huang L, Wang J, Shi D, Li Y, et al. A clinical-radiomics nomogram for the preoperative prediction of lung metastasis in colorectal cancer patients with indeterminate pulmonary nodules. Eur Radiol. 2019;29:439–49.CrossRefPubMed Hu T, Wang S, Huang L, Wang J, Shi D, Li Y, et al. A clinical-radiomics nomogram for the preoperative prediction of lung metastasis in colorectal cancer patients with indeterminate pulmonary nodules. Eur Radiol. 2019;29:439–49.CrossRefPubMed
16.
go back to reference Yang Q-K, Lai Q-Y, Wang Y, Wang Y, Yao Z-X, Zhang X-J. Establishment and validation of prognostic nomograms to predict overall survival and cancer-specific survival for patients with osteosarcoma. neo. 2021;68:434–46.CrossRef Yang Q-K, Lai Q-Y, Wang Y, Wang Y, Yao Z-X, Zhang X-J. Establishment and validation of prognostic nomograms to predict overall survival and cancer-specific survival for patients with osteosarcoma. neo. 2021;68:434–46.CrossRef
17.
go back to reference Lu S, Wang Y, Liu G, Wang L, Wu P, Li Y, et al. Construction and validation of nomogram to predict distant metastasis in osteosarcoma: a retrospective study. J Orthop Surg Res. 2021;16:231.CrossRefPubMedPubMedCentral Lu S, Wang Y, Liu G, Wang L, Wu P, Li Y, et al. Construction and validation of nomogram to predict distant metastasis in osteosarcoma: a retrospective study. J Orthop Surg Res. 2021;16:231.CrossRefPubMedPubMedCentral
18.
go back to reference Zhou Z, Wang J, Fang L, Ma J, Guo M. A nomogram for predicting overall survival in patients with Ewing sarcoma: a SEER-based study. BMC Musculoskelet Disord. 2020;21:737.CrossRefPubMedPubMedCentral Zhou Z, Wang J, Fang L, Ma J, Guo M. A nomogram for predicting overall survival in patients with Ewing sarcoma: a SEER-based study. BMC Musculoskelet Disord. 2020;21:737.CrossRefPubMedPubMedCentral
20.
go back to reference Reddy GT, Reddy MPK, Lakshmanna K, Rajput DS, Kaluri R, Srivastava G. Hybrid genetic algorithm and a fuzzy logic classifier for heart disease diagnosis. Evol Intel. 2020;13:185–96.CrossRef Reddy GT, Reddy MPK, Lakshmanna K, Rajput DS, Kaluri R, Srivastava G. Hybrid genetic algorithm and a fuzzy logic classifier for heart disease diagnosis. Evol Intel. 2020;13:185–96.CrossRef
21.
go back to reference Abbas S, Jalil Z, Javed AR, Batool I, Khan MZ, Noorwali A, et al. BCD-WERT: a novel approach for breast cancer detection using whale optimization based efficient features and extremely randomized tree algorithm. PeerJ Comput Sci. 2021;7: e390.CrossRefPubMedPubMedCentral Abbas S, Jalil Z, Javed AR, Batool I, Khan MZ, Noorwali A, et al. BCD-WERT: a novel approach for breast cancer detection using whale optimization based efficient features and extremely randomized tree algorithm. PeerJ Comput Sci. 2021;7: e390.CrossRefPubMedPubMedCentral
22.
go back to reference Rojas GA, Hubbard AK, Diessner BJ, Ribeiro KB, Spector LG. International trends in incidence of osteosarcoma (1988–2012). Int J Cancer. 2021;149:1044–53.CrossRefPubMedPubMedCentral Rojas GA, Hubbard AK, Diessner BJ, Ribeiro KB, Spector LG. International trends in incidence of osteosarcoma (1988–2012). Int J Cancer. 2021;149:1044–53.CrossRefPubMedPubMedCentral
23.
go back to reference Klangjorhor J, Pongnikorn D, Phanphaisarn A, Chaiyawat P, Teeyakasem P, Suksakit P, et al. An analysis of the incidence and survival rates of bone sarcoma patients in thailand: reports from population-based cancer registries 2001–2015. Cancer Epidemiol. 2022;76: 102056.CrossRefPubMed Klangjorhor J, Pongnikorn D, Phanphaisarn A, Chaiyawat P, Teeyakasem P, Suksakit P, et al. An analysis of the incidence and survival rates of bone sarcoma patients in thailand: reports from population-based cancer registries 2001–2015. Cancer Epidemiol. 2022;76: 102056.CrossRefPubMed
24.
go back to reference Luetke A, Meyers PA, Lewis I, Juergens H. Osteosarcoma treatment—where do we stand? A state of the art review. Cancer Treat Rev. 2014;40:523–32.CrossRefPubMed Luetke A, Meyers PA, Lewis I, Juergens H. Osteosarcoma treatment—where do we stand? A state of the art review. Cancer Treat Rev. 2014;40:523–32.CrossRefPubMed
25.
go back to reference Grünewald TGP, Cidre-Aranaz F, Surdez D, Tomazou EM, de Álava E, Kovar H, et al. Ewing sarcoma. Nat Rev Dis Primers. 2018;4:1–22.CrossRef Grünewald TGP, Cidre-Aranaz F, Surdez D, Tomazou EM, de Álava E, Kovar H, et al. Ewing sarcoma. Nat Rev Dis Primers. 2018;4:1–22.CrossRef
26.
28.
go back to reference Liu Z, Liu L, Weng S, Guo C, Dang Q, Xu H, et al. Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer. Nat Commun. 2022;13:816.CrossRefPubMedPubMedCentral Liu Z, Liu L, Weng S, Guo C, Dang Q, Xu H, et al. Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer. Nat Commun. 2022;13:816.CrossRefPubMedPubMedCentral
29.
go back to reference Liu Z, Guo C, Dang Q, Wang L, Liu L, Weng S, et al. Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer. EBioMedicine. 2021;75: 103750.CrossRefPubMedPubMedCentral Liu Z, Guo C, Dang Q, Wang L, Liu L, Weng S, et al. Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer. EBioMedicine. 2021;75: 103750.CrossRefPubMedPubMedCentral
30.
go back to reference Zhou S-N, Jv D-W, Meng X-F, Zhang J-J, Liu C, Wu Z-Y, et al. Feasibility of machine learning-based modeling and prediction using multiple centers data to assess intrahepatic cholangiocarcinoma outcomes. Ann Med. 2023;55:215–23.CrossRefPubMed Zhou S-N, Jv D-W, Meng X-F, Zhang J-J, Liu C, Wu Z-Y, et al. Feasibility of machine learning-based modeling and prediction using multiple centers data to assess intrahepatic cholangiocarcinoma outcomes. Ann Med. 2023;55:215–23.CrossRefPubMed
31.
go back to reference Wang J, Zhanghuang C, Tan X, Mi T, Liu J, Jin L, et al. A Nomogram for predicting cancer-specific survival of osteosarcoma and Ewing’s sarcoma in children: a SEER database analysis. Front Public Health. 2022;10: 837506.CrossRefPubMedPubMedCentral Wang J, Zhanghuang C, Tan X, Mi T, Liu J, Jin L, et al. A Nomogram for predicting cancer-specific survival of osteosarcoma and Ewing’s sarcoma in children: a SEER database analysis. Front Public Health. 2022;10: 837506.CrossRefPubMedPubMedCentral
32.
go back to reference Kim MS, Lee S-Y, Lee TR, Cho WH, Song WS, Koh J-S, et al. Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma. Ann Oncol. 2009;20:955–60.CrossRefPubMed Kim MS, Lee S-Y, Lee TR, Cho WH, Song WS, Koh J-S, et al. Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma. Ann Oncol. 2009;20:955–60.CrossRefPubMed
33.
go back to reference Bacci G, Longhi A, Versari M, Mercuri M, Briccoli A, Picci P. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy. Cancer. 2006;106:1154–61.CrossRefPubMed Bacci G, Longhi A, Versari M, Mercuri M, Briccoli A, Picci P. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy. Cancer. 2006;106:1154–61.CrossRefPubMed
34.
go back to reference Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. JCO. 2002;20:776–90.CrossRef Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. JCO. 2002;20:776–90.CrossRef
35.
go back to reference Berner K, Bruland ØS. Prognostic impact of proximal versus distal localization in extremity long bone osteosarcomas. Anticancer Res. 2019;39:2459–66.CrossRefPubMed Berner K, Bruland ØS. Prognostic impact of proximal versus distal localization in extremity long bone osteosarcomas. Anticancer Res. 2019;39:2459–66.CrossRefPubMed
36.
go back to reference Wan Z-H, Huang Z-H, Chen L-B. Survival outcome among patients with Ewing’s sarcoma of bones and joints: a population-based cohort study. Sao Paulo Med J. 2017;136:116–22.CrossRefPubMedPubMedCentral Wan Z-H, Huang Z-H, Chen L-B. Survival outcome among patients with Ewing’s sarcoma of bones and joints: a population-based cohort study. Sao Paulo Med J. 2017;136:116–22.CrossRefPubMedPubMedCentral
37.
go back to reference Bieling P, Rehan N, Winkler P, Helmke K, Maas R, Fuchs N, et al. Tumor size and prognosis in aggressively treated osteosarcoma. JCO. 1996;14:848–58.CrossRef Bieling P, Rehan N, Winkler P, Helmke K, Maas R, Fuchs N, et al. Tumor size and prognosis in aggressively treated osteosarcoma. JCO. 1996;14:848–58.CrossRef
Metadata
Title
Incidence trends, overall survival, and metastasis prediction using multiple machine learning and deep learning techniques in pediatric and adolescent population with osteosarcoma and Ewing’s sarcoma: nomogram and webpage
Authors
Chengyuan Zhou
Han Li
Hao Zeng
Pan Wang
Publication date
27-09-2024
Publisher
Springer International Publishing
Published in
Clinical and Translational Oncology
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-024-03717-9

2024 ESMO Congress

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

  • Webinar | 01-10-2024 | 12:30 (CEST)

Live event concluded

In this webinar, Professor Martin Dreyling and an esteemed, international panel of CAR-T experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by: Novartis Pharma AG

Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare
Get a reminder for the on-demand version